SCHEMBL186417

SCHEMBL186417

CCC(CC(N)=O)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.56
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
PKM P14618 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
GABBR2 O75899 1/20 0.52
GABBR1 Q9UBS5 1/20 0.52
CYP2C19 P33261 3/20 0.49
LMNA P02545 3/20 0.46
POLB P06746 1/20 0.46
SLC6A3 Q01959 3/20 0.44
DRD3 P35462 2/20 0.44
ADORA3 P0DMS8 1/20 0.44
EDNRB P24530 1/20 0.44
MAPK1 P28482 1/20 0.44
MC4R P32245 1/20 0.44
MC3R P41968 1/20 0.44
DRD2 P14416 1/20 0.44
NOS3 P29474 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL186239 1.00 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP2D6PKMSMN1; SMN2
SCHEMBL186231 1.00 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP2D6PKMSMN1; SMN2
SCHEMBL9105247 0.88 ALDH1A1 (0.63) ALDH1A1CYP1A2CYP2D6PKMSMN1; SMN2
SCHEMBL184884 0.85 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP2D6PKMSMN1; SMN2
SCHEMBL15614666 0.85 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP2D6PKMSMN1; SMN2
SCHEMBL2484805 0.84 GABBR2 (0.66) CYP1A2CYP2D6GABBR2GABBR1CYP2C19
SCHEMBL6174106 0.84 GABBR2 (0.66) CYP1A2CYP2D6GABBR2GABBR1CYP2C19
SCHEMBL240789 0.84 GABBR2 (0.66) CYP1A2CYP2D6GABBR2GABBR1CYP2C19
SCHEMBL185573 0.83 CYP2C19 (0.50) ALDH1A1CYP1A2CYP2D6SMN1; SMN2CYP2C19
SCHEMBL16588649 0.83 ALDH1A1 (0.59) ALDH1A1CYP1A2CYP2D6PKMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401260-A1 DIOXO-IMIDAZOLIDINE DERIVATIVES, WHICH INHIBIT THE ENZYME SOAT-1, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM Galderma Research & Development (FR) 2012-01-04 EP claimed
WO-2010097465-A1 DIOXO-IMIDAZOLIDINE DERIVATIVES, WHICH INHIBIT THE ENZYME SOAT-1, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM GALDERMA RESEARCH & DEVELOPMENT (FR) 2010-09-02 WO claimed
EP-2864284-B1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO KGAA (DE) 2017-07-05 EP disclosed
WO-2014079850-A1 SUBSTITUTED HETEROCYCLIC DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2014-05-30 WO disclosed
CN-102666505-A Pesticidal heterocyclic compounds BAYER CROPSCIENCE AG 2012-09-12 CN disclosed
EP-2401260-A1 DIOXO-IMIDAZOLIDINE DERIVATIVES, WHICH INHIBIT THE ENZYME SOAT-1, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM Galderma Research & Development (FR) 2012-01-04 EP disclosed
CN-102197023-A Compounds for the treatment of ophthalmic diseases and disorders ACUCELA INC 2011-09-21 CN disclosed
CN-101395154-B 8-azabicyclo [3.2.1] octane compounds as mu opioid receptor antagonists THERAVANCE INC 2011-01-19 CN disclosed
WO-2010097465-A1 DIOXO-IMIDAZOLIDINE DERIVATIVES, WHICH INHIBIT THE ENZYME SOAT-1, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM GALDERMA RESEARCH & DEVELOPMENT (FR) 2010-09-02 WO disclosed
CN-101395154-A 8-azabicyclo [3.2.1] octane compounds as mu opioid receptor antagonists THERAVANCE INC (US) 2009-03-25 CN disclosed
CN-1900080-A Inhibitors of cruzipain and other cysteine proteases AMURA THERAPEUTICS LTD (GB) 2007-01-24 CN disclosed
CN-1269822-C Inhibitors of kruenza protease and other cysteine proteases AMURA THERAPEUTICS LTD (GB) 2006-08-16 CN disclosed